Company profile

Cydar

Cardiology & Cardiovascular Health

Company profile

About Cydar

Cydar Medical is a medical technology company founded in 2014 that specializes in transforming minimally invasive image-guided surgery through artificial intelligence and advanced imaging solutions. The company's flagship product, Cydar Maps, is a comprehensive Software-as-a-Medical Device (SaMD) platform that supports the entire surgical workflow—from pre-operative planning to intraoperative guidance and post-operative analysis. The Cydar Image Guided Surgery Platform (CIGSP) leverages cloud-based AI technology and data fusion to empower clinical teams with actionable insights for faster, easier, and more informed surgical decisions. The platform creates 3D surgical plans using AI-enhanced vessel measurements, provides real-time intraoperative guidance with surgical precision, and enables automatic volume assessment for monitoring patient outcomes. Clinical evidence demonstrates significant improvements including reductions in radiation exposure, procedure times, and contrast agent use. Cydar Medical serves healthcare providers including hospitals, health systems, and vascular surgery departments primarily in the United States, United Kingdom, and European Union. The platform is designed for complex endovascular aortic procedures and other image-guided minimally invasive surgeries. The company's technology integrates seamlessly with existing hospital systems including PACS and operating room displays, while maintaining GDPR and HIPAA compliance. Cydar also partners with innovative software companies to accelerate the deployment of AI applications in surgical settings, providing a centralized framework that simplifies procurement, implementation, and ongoing support for healthcare institutions.

Company description Cydar official website

Primary marketCardiology & Cardiovascular Health
Commercial modelCommercial information available on request
Company presenceLinkedIn
Work at Cydar?

Claim this profile to manage Company information and connect with the Health AI Central audience.

Claim this listing

01 · Operating footprint

Where the Company operates

Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.

Clinical focus

  • Complex EVAR (Endovascular Aneurysm Repair)
  • Endovascular aortic procedures
  • Image-guided minimally invasive surgical procedures
  • Vascular surgery

Who it serves

  • Academic Medical Centers
  • Health Systems
  • Hospitals
  • Vascular Surgery Departments

Deployment & integration

Cloud Saas · Hybrid deployment with recorded integration context.

Recorded integration context: Imaging systems, Operating room displays, PACS.

Geographic context

MarketsEuropean Union · United Kingdom · United States
Company sourceOfficial website

Company milestones

Platform expansion

Expansion of Cydar Maps solution for greater efficiency (2025), ongoing deployment across major healthcare systems

Partnerships

Recorded partners

  • Healthcare providers across US, EU, and UK
  • Software companies deploying AI applications via CIGSP platform

02 · Flagship portfolio

Products, workflows, and platform capabilities

Selected source-backed Company products and the available commercial context.

Automatic Volume Assessment Tool

Monitor patient outcomes pre- and post-surgery with automated volume assessment

Software · Cloud SaaSCompany source

Cydar Companion App

iOS and Android app for secure photo sharing and 24/7 support access

Software · Cloud SaaSCompany source

Cydar Image Guided Surgery Platform (CIGSP)

Platform connecting operating rooms and cloud for Software-as-a-Medical Device applications

Platform · HybridCompany source

Cydar Maps

AI-powered 3D surgical planning and guidance platform for minimally invasive image-guided surgery

Platform · HybridCompany source

Intraoperative Guide

Guiding your procedure with surgical precision during surgery

Software · HybridCompany source

Plan+

Create 3D surgical plans leveraging AI enhanced vessel measurements and insights

Software · Cloud SaaSCompany source

03 · Research intelligence

Research Intelligence evidence

Publications, preprints, clinical validation, and regulatory records in Evidence Position order.

04 · Company-reported outcomes

Outcomes and case studies

Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.

Reduction in radiation exposure

Percentage reduction during procedures

Reduction in procedure times

Percentage reduction in surgical duration

Reduction in contrast agent use

Percentage reduction in contrast media

Hospital Universitari de Girona Doctor Josep Trueta

Better surgical planning and procedure execution for vascular surgery cases

Surgeon will not operate without the planning software

University of Chicago Medicine

Managing complex anatomy in vascular surgery and endovascular therapy

Tremendous impact in operating room environment for complex anatomy cases

USF Health Morsani School of Medicine

Growing complex EVAR program and improving surgical outcomes

Demonstrated value in reducing radiation, contrast, and procedure time; improved confidence in device positioning and simplified branch cannulation

05 · Leadership

Leadership team

Leadership profiles and professional links from the current Company record.

Paul Mussenden

Paul Mussenden

Chief Executive Officer

LinkedIn

Graeme Penney

Chief Scientific Officer & Co-Founder

Vanisha Mistry

VP of Operations

Rob Hague

Chief Software Architect

Kenneth Hitchner

Chairman of the Board

Andrew Wolfsman

Pembroke Investment Director

06 · Company updates

Updates from Cydar

Recent articles published on Cydar's official website.

07 · HAIC coverage

Coverage and analysis

Health AI Central reporting that mentions this Company.

No HAIC coverage is currently linked to this Company.

08 · Official presence

Company sources and channels

Curated official destinations from the active Company record.

09 · Market pathway

Additional Companies in this Market

Other active Companies in the same market, selected alphabetically from the HAIC directory.

Market context

Cardiology & Cardiovascular Health

Companies applying AI to cardiovascular disease detection, ECG/EKG analysis, heart failure management, cardiac imaging, arrhythmia detection, or cardiovascular risk assessment. Includes AI-powered cardiac diagnostics, non-invasive hemodynamic monitoring, and tools for early detection and personalized management of heart conditions.

Explore the full market directory or compare this Company with additional active profiles.

View all Companies in this market

10 · Pro research

Coming soon

Expanded Company research is in development.

Health AI Central Pro · Coming Soon

Deeper Company research is coming soon.

Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.

ResearchEvidence analysis

Linked research, clinical, and regulatory source pathways.

CompanyTechnical context

Expanded product, deployment, integration, and partnership research.

MethodSource & review record

Record-level provenance and review context.

Coming Soon